Financial Times FT.com

Chinese medicine

By Emiliya Mychasuk

Published: October 29 2009 02:00 | Last updated: October 29 2009 02:00

AstraZeneca boss David Brennan has an excuse for missing his third-quarter results today, jetting to Beijing to join the advisory board of the Tsinghua School of Economics and Management. The Chinese institution has been a hot ticket for western chairman and CEOs in recent years with Goldman Sachs' Lloyd Blankfein, Blackstone's Steve Schwarzman and K-Mart's Lee Scott among more than 40 big names. While Mr Brennan is away, finance director Simon Lowth is minding the drugstore.

people@ft.com

You have viewed your allowance of free articles. If you wish to view more, click the button below.

Read this